DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 159 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $199,000 | +70.1% | 35,617 | +8.0% | 0.31% | +1729.4% |
| Q3 2019 | $117,000 | -11.4% | 32,985 | 0.0% | 0.02% | -19.0% |
| Q2 2019 | $132,000 | -45.2% | 32,985 | 0.0% | 0.02% | -48.8% |
| Q1 2019 | $241,000 | -15.4% | 32,985 | 0.0% | 0.04% | -22.6% |
| Q4 2018 | $285,000 | 0.0% | 32,985 | +43.4% | 0.05% | +8.2% |
| Q3 2018 | $285,000 | -12.3% | 23,008 | +8.3% | 0.05% | -19.7% |
| Q2 2018 | $325,000 | +371.0% | 21,247 | +508.8% | 0.06% | +369.2% |
| Q1 2018 | $69,000 | – | 3,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $48,347,000 | 7.21% |
| Avidity Partners Management LP | 780,000 | $4,462,000 | 2.81% |
| Bain Capital Public Equity Management II, LLC | 3,559,547 | $20,361,000 | 1.93% |
| Senvest Management, LLC | 3,988,889 | $22,816,000 | 1.55% |
| Chicago Capital, LLC | 3,999,740 | $22,879,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 1,080,000 | $6,178,000 | 0.68% |
| JACKSON SQUARE CAPITAL, LLC | 143,180 | $819,000 | 0.47% |
| RA Capital Management | 2,365,912 | $13,533,000 | 0.41% |
| Crow Point Partners, LLC | 35,617 | $199,000 | 0.31% |
| Rock Springs Capital Management LP | 1,575,000 | $9,009,000 | 0.28% |